The high-affinity TSPO ligand [18 F]GE180 was first used by Albert and colleagues for TSPO-PET imaging of untreated and pretreated GBM and showed remarkably high tumor-to-background contrast and TSPO-PET signal even in areas without contrast-enhancement on MRI [2]. This evidence concerns the gene TSPO and glioblastoma.